Press release
Anti Osteoporosis Therapy and Fracture Healing Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030
Global anti osteoporosis therapy and fracture healing market is estimated to grow at a CAGR of 3.0% during the forecast period. A study was conducted to calculate the number of patients with hip fractures who subsequently initiate treatment with anti-osteoporotic medicine. Copenhagen University Hospital, Herlev, conducted a study from June 2019 to May 2020. A total of 627 patients were admitted with a hip or near-hip fracture in the one-year study period. At the time of the hip fracture, 570 patients were 65 years of age or older, and 74% were women. Men were slightly younger than women at the time of fracture. At follow-up, 26% of the patients had died. However, the study unveiled that men had a higher death rate than women. Additionally, various initiatives programs, and spending on R&D by regulatory bodies, strengthen the market growth. For instance, in June 2021, a new joint initiative by the International Osteoporosis Foundation and Asia Pacific Orthopaedic Association calls on orthopaedic surgeons to strengthen collaboration with physicians to improve secondary fracture prevention and patient outcomes. The new publication features key messages related to fracture management, post-fracture rehabilitation, fracture healing and national fracture registries. Asian countries are facing the most marked increase in fragility fractures globally, with the number of people at high fracture risk expected to double from 2010-2030.To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/anti-osteoporosis-therapy-and-fracture-healing-market
Moreover, according to the International osteoporosis foundation, in 2022, there are 6.2 million Australians over the age of 50 with osteoporosis or osteopenia. That is a 31% increase from 2012. as per the same source, Asian countries will face the most marked increase in fractures globally, with projections suggesting that by 2050, 50% of hip fractures will occur in Asia, the majority of which will happen in China. The number of individuals at high fracture risk in the region is expected to double from 2010- 2030.
Market Coverage
• The market number available for - 2022-2030
• Base year- 2022
• Forecast period- 2023-2030
• Segment Covered-
o By Drug Type
o By Route of Administration
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- including GlaxoSmithKline, Medtronic Plc, Merck & Co. Inc.,Pfizer, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Anti Osteoporosis Therapy and Fracture Healing Market Report Segment
By Drug Type
• Calcitonin
• Bisphosphonates
o Alendronate (Fosamax)
o Risedronate (Actonel)
o Ibandronate (Boniva)
o Zoledronic acid (Reclast)
• Hormone Replacement Therapy
• Anabolics
• Others (denosumab, and raloxifene)
By Route of Administration
• Oral
• Injectable
By Distribution Channel
• Clinics
• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies
• E-Commerce
A full report of Anti Osteoporosis Therapy and Fracture Healing Market available @ https://www.omrglobal.com/industry-reports/anti-osteoporosis-therapy-and-fracture-healing-market
Global Anti Osteoporosis Therapy and Fracture Healing Market Report Segment by Region
North America
• United States
• Canada
Europe
• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe
Asia-Pacific
• China
• Japan
• India
• Rest of Asia-Pacific
Rest of the World
• Middle East & Africa
• Latin America
Company Profiles
• Amgen Inc
• Bioventus
• Djo LLC
• Eli Lilly and Co.
• F. Hoffmann-La Roche Ltd
• Orthofix US LLC
• OssaTechnics
• Osteo-Pharma BV
• Stryker
• Teva Pharmaceutical Industries Ltd.
Reasons to Buying From us -
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti Osteoporosis Therapy and Fracture Healing Market Share, Trends, Future Outlook, Analysis and Forecast 2023-2030 here
News-ID: 3257326 • Views: …
More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…

Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…

Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…

Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Osteoporosis
Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period?
The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate?
The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected…
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market
The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of…
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss.
The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss.
To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample
Although osteoporosis cannot be treated, it can be slowed down or…
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related…